Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates near-infrared selenocysteine imaging across inflammation models, highlighting a new strategy to screen herbal anti-inflammatory compounds.
Inflammation, a central process in numerous diseases, plays a crucial role in hepatic disorders, arthritis, cardiac conditions, and neurodegenerative ailments. Given the lack of effective anti-inflammatory drugs, it is imperative to assess inflammation severity and explore novel therapeutics. Selenocysteine (Sec), a key mediator of selenium’s biological function, is closely involved in anti-inflammatory responses. We have synthesized a novel near-infrared fluorescent probe, Sec-BDP, which can image Sec dynamics in vivo with high selectivity and sensitivity. Sec-BDP detects Sec at concentrations as low as 0.085 μM. Utilizing this probe, we visualized Sec levels in cell, zebrafish, and mouse inflammation models, enabling a clear assessment of inflammation severity. To screen for drug candidates, Sec-BDP was integrated with ultrahigh performance liquid chromatography quadrupole time-of-flight mass spectrometry to identify potent anti-inflammatory compounds in Astragalus membranaceus, such as 5-O-methylvisammioside. Imaging of Sec with Sec-BDP provides insights into Sec-related diseases and aids in discovering new treatments. This probe advances selenium biology and promises more targeted therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: